Posts

Showing posts from August, 2017

Specialty Chemicals Market on the Road to Recovery to Reach $884 Billion Due to Robust Development Activity in Emerging Regions

Image
Industry Experts released the new market research report " Select Specialty Chemicals Applications - A Global End-Use Industry Analysis ". As per the study, agrochemicals segment leads the market with US$218 billion in 2017 while Asia-Pacific is expected to witness the fastest growth during the 2017-2022 analysis period, owing to the robust growth in Electronic Chemicals applications as this region is the home for large number of companies engaged in electrical & electronic component manufacturing. As the name indicates, Specialty Chemicals are chemical products that are produced keeping a special or specific purpose in mind, with a greater emphasis on performance or function instead of composition. These can comprise individual chemical entities or complex formulations with ingredients that have a major role to play in the processing and performance of final products derived from them. The range of products and services encompassed by the specialty chemicals industry

Ageing Population and Burden of Disease Contribute to Growth in Demand for IVD to Reach $83 Billion by 2022

Image
Industry Experts released the 2017 version of its global report on In Vitro Diagnostics market. The new report titled ‘ In Vitro Diagnostics – A Global Market Overview ’ analyzes the global market of In Vitro Diagnostics (IVD) by geographic region, major country and prominent IVD technologies while special citation on end-use sectors in the United States and German markets. Clinical Chemistry is estimated to be the principal technology segment in the global IVD market cornering a market of $19.7 billion in 2017. The In Vitro Diagnostics (IVD) industry is being positively impacted due to several factors that include rising global and regional trends of aging populations, growth in non-communicable diseases and greater affordability for treatment. Due to an increase in healthcare costs, greater weight is being given to evidence-based medicine with the aim of improving patient outcomes. The need for diagnostic devices in various conditions has been growing due to an aging population,